NCT01730118 2022-09-10Ad/HER2/Neu Dendritic Cell Cancer Vaccine TestingNational Institutes of Health Clinical Center (CC)Phase 1 Completed33 enrolled 18 charts
NCT03384316 2020-09-09Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced CancerNational Institutes of Health Clinical Center (CC)Phase 1 Completed11 enrolled 18 charts